Home › Companies › CATALYST PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed May 21, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 21, 2024: 10 items on CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed May 21, 2024: 10 passed (calculated).
Meeting of August 22, 2023: 10 items on CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed August 25, 2023: 10 passed (calculated).
Notable dissent: 1 director (19.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Explore CATALYST PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are CATALYST PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. CATALYST PHARMACEUTICALS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Richard J. Daly | 88,161,224 | 1,489,928 | 193,687 | -- | 11,817,471 | 98% | Passed (calculated) | — |
| Elect Director: Patrick J. McEnany | 86,093,354 | 3,561,412 | 190,073 | -- | 11,817,471 | 96% | Passed (calculated) | — |
| Elect Director: Donald A. Denkhaus | 85,937,799 | 3,717,631 | 189,409 | -- | 11,817,471 | 96% | Passed (calculated) | — |
| Elect Director: Molly Harper | 86,018,457 | 3,637,844 | 188,538 | -- | 11,817,471 | 96% | Passed (calculated) | — |
| Elect Director: Charles B. O'Keeffe | 84,926,089 | 4,730,350 | 188,400 | -- | 11,817,471 | 95% | Passed (calculated) | — |
| Elect Director: Tamar Thompson | 85,049,382 | 4,604,945 | 190,512 | -- | 11,817,471 | 95% | Passed (calculated) | — |
| Elect Director: David S. Tierney | 85,767,244 | 3,885,606 | 191,989 | -- | 11,817,471 | 96% | Passed (calculated) | — |
| 2. Approval of an amendment to our 2018 Stock Incentive Plan | 86,817,240 | 2,859,403 | 168,196 | -- | 11,817,471 | 97% | Passed (calculated) | — |
| 3. Approval, on an advisory basis, of the 2023 compensation of our named executive officers | 84,194,484 | 5,468,681 | 181,674 | -- | 11,817,471 | 94% | Passed (calculated) | — |
| 4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 99,551,894 | 2,031,301 | 79,115 | -- | -- | 98% | Passed (calculated) | — |
Source: CATALYST PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 21, 2024 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Patrick J. McEnany | 74,672,480 | 1,183,192 | 102,149 | -- | 12,395,336 | 98% | Passed (calculated) | — |
| Elect Director: Richard J. Daly | 75,023,592 | 828,218 | 106,011 | -- | 12,395,336 | 99% | Passed (calculated) | — |
| Elect Director: Donald A. Denkhaus | 74,450,695 | 1,229,833 | 277,293 | -- | 12,395,336 | 98% | Passed (calculated) | — |
| Elect Director: Molly Harper | 74,886,349 | 795,997 | 275,475 | -- | 12,395,336 | 99% | Passed (calculated) | — |
| Elect Director: Charles B. O'Keeffe | 74,257,213 | 1,421,102 | 279,506 | -- | 12,395,336 | 98% | Passed (calculated) | — |
| Elect Director: Tamar Thompson | 75,486,875 | 193,861 | 277,085 | -- | 12,395,336 | 99.7% | Passed (calculated) | — |
| Elect Director: David S. Tierney | 60,628,318 | 15,052,826 | 276,677 | -- | 12,395,336 | 80% | Passed (calculated) | — |
| 2. Approval of an amendment to our 2018 Stock Incentive Plan | 73,160,219 | 2,659,621 | 137,981 | -- | 12,395,336 | 96% | Passed (calculated) | — |
| 3. Approval, on an advisory basis, of 2022 compensation of our named executive officers | 72,610,991 | 2,909,780 | 437,050 | -- | 12,395,336 | 96% | Passed (calculated) | — |
| 4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 | 87,621,416 | 277,620 | 454,121 | -- | -- | 99.7% | Passed (calculated) | — |
Source: CATALYST PHARMACEUTICALS INC., Form 8-K, filed with the SEC on August 25, 2023 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
334 asset managers disclosed a vote on at least one CATALYST PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CATALYST PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held May 21, 2024.
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Charles B. O'Keeffe”): 84,926,089 for, 4,730,350 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,914,658 | 2,335 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 43,068,653 for, 37,502 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Donald A. Denkhaus as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Donald A. Denkhaus”): 85,937,799 for, 3,717,631 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 43,070,623 for, 35,532 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Molly Harper as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Molly Harper”): 86,018,457 for, 3,637,844 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 43,070,623 for, 35,532 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Patrick J. McEnany as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick J. McEnany”): 86,093,354 for, 3,561,412 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,407 | 1,586 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 42,984,937 for, 111,294 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Richard J. Daly as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Richard J. Daly”): 88,161,224 for, 1,489,928 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,407 | 1,586 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 43,083,019 for, 23,136 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Tamar Thompson as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Tamar Thompson”): 85,049,382 for, 4,604,945 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 42,821,939 for, 284,216 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David S. Tierney”): 85,767,244 for, 3,885,606 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of CATALYST PHARMACEUTICALS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “ELECT DIRECTOR DAVID S. TIERNEY” (2 managers, 9,924 for, 86,986 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,914,658 | 2,335 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 42,971,743 for, 37,502 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held August 22, 2023.
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Charles B. O'Keeffe”): 74,257,213 for, 1,421,102 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,755,270 for, 28,368 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David S. Tierney”): 60,628,318 for, 15,052,826 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 28,304,464 for, 10,479,174 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 71,307 | 7,370,019 | 0 | 0 | Against |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 0 | 2,092,020 | 0 | 0 | Against |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 356,094 | 0 | 0 | Against |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 239,217 | 24,729 | 0 | 0 | Mixed |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect Donald A. Denkhaus as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Donald A. Denkhaus”): 74,450,695 for, 1,229,833 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,755,520 for, 28,118 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect Molly Harper as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Molly Harper”): 74,886,349 for, 795,997 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,755,520 for, 28,118 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect Patrick J. McEnany as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick J. McEnany”): 74,672,480 for, 1,183,192 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,679,298 for, 104,340 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect Richard J. Daly as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Richard J. Daly”): 75,023,592 for, 828,218 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,755,520 for, 28,118 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To elect Tamar Thompson as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Tamar Thompson”): 75,486,875 for, 193,861 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,768,378 for, 15,260 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Meeting held May 21, 2024.
Combines 2 wordings of this item as funds reported it.
2% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 12,056,213 | 0 | 0 | Against |
| Vanguard | 0 | 7,681,821 | 0 | 0 | Against |
| State Street | 5,393 | 5,911,600 | 0 | 0 | Against |
| Fidelity | 0 | 2,606,331 | 0 | 0 | Against |
| Dimensional | 0 | 2,312,134 | 0 | 0 | Against |
| Royce | 0 | 1,467,476 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,016,458 | 0 | 0 | Against |
| T. Rowe Price | 0 | 911,552 | 0 | 0 | Against |
| Invesco | 0 | 865,133 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 0 | 672,701 | 0 | 0 | Against |
| American Century | 0 | 597,439 | 0 | 0 | Against |
| OBERWEIS FUNDS | 0 | 458,400 | 0 | 0 | Against |
| TIAA | 0 | 426,573 | 0 | 0 | Against |
| Janus Detroit Street Trust | 0 | 330,359 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 311,886 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 306,731 | 0 | 0 | Against |
| Northern Trust | 0 | 297,820 | 0 | 0 | Against |
| RBB FUND, INC. | 0 | 290,561 | 0 | 0 | Against |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 0 | 276,446 | 0 | 0 | Against |
| Jackson National | 0 | 267,975 | 0 | 0 | Against |
| First Trust | 0 | 223,487 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 195,270 | 0 | 0 | Against |
| BNY Mellon | 0 | 178,485 | 0 | 0 | Against |
| FRANKLIN VALUE INVESTORS TRUST | 0 | 169,495 | 0 | 0 | Against |
Fund voting reports, all 91 managers: 305,605 for, 42,602,842 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held August 22, 2023.
Combines 5 wordings of this item as funds reported it.
0% of fund votes cast · no official result
Description as filed by funds: PROPOSAL FIVE - To transact such other business as may properly come before the meeting.
The 66 asset managers below reported 36,006,903 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 9,142,804 | 0 | 0 | Against |
| State Street | 0 | 7,441,326 | 0 | 0 | Against |
| Vanguard | 0 | 6,611,178 | 0 | 0 | Against |
| Dimensional | 0 | 2,092,020 | 0 | 0 | Against |
| Fidelity | 0 | 1,951,374 | 0 | 0 | Against |
| Invesco | 0 | 1,101,996 | 0 | 0 | Against |
| T. Rowe Price | 0 | 813,918 | 0 | 0 | Against |
| American Century | 0 | 745,781 | 0 | 0 | Against |
| Royce | 0 | 740,385 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 435,872 | 0 | 0 | Against |
| Northern Trust | 0 | 368,585 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 356,094 | 0 | 0 | Against |
| Equitable | 0 | 269,890 | 0 | 0 | Against |
| TIAA | 0 | 259,204 | 0 | 0 | Against |
| Allspring | 0 | 256,552 | 0 | 0 | Against |
| Janus Detroit Street Trust | 0 | 244,270 | 0 | 0 | Against |
| Voya | 0 | 236,211 | 0 | 0 | Against |
| Goldman Sachs | 0 | 205,437 | 0 | 0 | Against |
| BNY Mellon | 0 | 202,143 | 0 | 0 | Against |
| AllianceBernstein | 0 | 186,030 | 0 | 0 | Against |
| OBERWEIS FUNDS | 0 | 183,400 | 0 | 0 | Against |
| Victory Capital | 0 | 165,407 | 0 | 0 | Against |
| First Trust | 0 | 164,343 | 0 | 0 | Against |
| ProShares | 0 | 147,764 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 143,704 | 0 | 0 | Against |
Showing the 25 largest of 66 asset managers. All 66 are in the interactive database (link above).
Meeting held August 22, 2023.
13% of fund votes cast · no official result
Description as filed by funds: TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING.
The 27 asset managers below reported 348,195 for, 2,340,532 against, 23,783 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 0 | 858,074 | 0 | 0 | Against |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Jackson National | 0 | 263,946 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 239,839 | 0 | 0 | Against |
| SEI | 0 | 178,664 | 0 | 0 | Against |
| World Funds Trust | 0 | 154,809 | 0 | 0 | Against |
| Russell Investments | 0 | 123,192 | 0 | 0 | Against |
| Federated Hermes | 0 | 93,445 | 0 | 0 | Against |
| ADVISORS' INNER CIRCLE FUND | 0 | 74,900 | 0 | 0 | Against |
| EntrepreneurShares Series Trust | 0 | 73,805 | 0 | 0 | Against |
| Allianz | 0 | 71,107 | 0 | 0 | Against |
| CITY NATIONAL ROCHDALE FUNDS | 0 | 51,899 | 0 | 0 | Against |
| John Hancock | 0 | 37,701 | 0 | 0 | Against |
| RBB FUND, INC. | 0 | 24,505 | 0 | 0 | Against |
| AuguStar | 0 | 0 | 23,783 | 0 | Abstain |
| Managed Portfolio Series | 0 | 22,901 | 0 | 0 | Against |
| Lincoln Financial | 16,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 16,849 | 0 | 0 | Against |
| Putnam | 0 | 14,779 | 0 | 0 | Against |
| NEW COVENANT FUNDS | 0 | 11,416 | 0 | 0 | Against |
| GPS Funds I | 0 | 10,835 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST II | 0 | 7,431 | 0 | 0 | Against |
| Pacer Funds Trust | 0 | 5,373 | 0 | 0 | Against |
| WILSHIRE MUTUAL FUNDS INC | 0 | 3,300 | 0 | 0 | Against |
| SYNTAX ETF TRUST | 0 | 1,762 | 0 | 0 | Against |
Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).
Meeting held August 22, 2023.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: PROPOSAL TWO - To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“2. Approval of an amendment to our 2018 Stock Incentive Plan”): 73,160,219 for, 2,659,621 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 0 | 745,781 | 0 | 0 | Against |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Fund voting reports, all 91 managers: 37,953,220 for, 828,370 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| CORNELL UNIVERSITY | 1,939 | 0 | 0 | 0 | For |
| PEDDOCK CAPITAL ADVISORS, LLC | 900 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 109 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 2,948 for, 563,392 unknown.
Meeting held May 21, 2024.
98% of fund votes cast · no official result
Description as filed by funds: Election of Directors To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.
The 66 asset managers below reported 39,700,114 for, 615,644 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,916,194 | 799 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 0 | 597,439 | 0 | 0 | Against |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 204,965 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
| Goldman Sachs | 141,147 | 0 | 0 | 0 | For |
| Principal | 127,499 | 0 | 0 | 0 | For |
| Victory Capital | 121,317 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. All 66 are in the interactive database (link above).
Meeting held May 21, 2024.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“2. Approval of an amendment to our 2018 Stock Incentive Plan”): 86,817,240 for, 2,859,403 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Jackson National | 243,246 | 0 | 0 | 0 | For |
| Russell Investments | 117,897 | 0 | 0 | 0 | For |
| Prudential/PGIM | 115,519 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 90,000 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 85,596 | 0 | 0 | 0 | For |
| SEI | 83,196 | 0 | 0 | 0 | For |
| TANAKA FUNDS INC | 81,098 | 0 | 0 | 0 | For |
| Allianz | 66,677 | 0 | 0 | 0 | For |
| Catholic Responsible Investments Funds | 60,985 | 0 | 0 | 0 | For |
| EntrepreneurShares Series Trust | 59,577 | 0 | 0 | 0 | For |
| Federated Hermes | 53,505 | 0 | 0 | 0 | For |
| Global X | 45,183 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 41,692 | 0 | 0 | 0 | For |
| John Hancock | 37,569 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 30,211 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 29,227 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,704 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,769 | 0 | 0 | 0 | For |
| Putnam | 0 | 14,111 | 0 | 0 | Against |
| Tema ETF Trust | 11,352 | 0 | 0 | 0 | For |
| GPS Funds I | 10,217 | 0 | 0 | 0 | For |
| TIMOTHY PLAN | 9,924 | 0 | 0 | 0 | For |
| NEW COVENANT FUNDS | 6,810 | 0 | 0 | 0 | For |
Fund voting reports, all 30 managers: 2,627,009 for, 14,111 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 500,200 for, 413,392 unknown.
Meeting held May 21, 2024.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the 2023 compensation of our named executive officers.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory basis, of the 2023 compensation of our named executive officers”): 84,194,484 for, 5,468,681 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 0 | 597,439 | 0 | 0 | Against |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 306,731 | 0 | 0 | Against |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 42,039,178 for, 1,066,977 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 7,922,822 | 2,274 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,045,754 | 0 | 0 | 0 | For |
| BlackRock | 3,760,560 | 15,065 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,507,305 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 2,485,040 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 0 | 1,457,090 | 0 | 0 | Against |
| T. Rowe Price | 1,197,635 | 0 | 0 | 0 | For |
| Northern Trust | 1,145,070 | 0 | 0 | 0 | For |
| Charles Schwab | 1,074,762 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,046,858 | 0 | 0 | 0 | For |
| Opaleye Management Inc. | 0 | 1,035,000 | 0 | 0 | Against |
| KENNEDY CAPITAL MANAGEMENT LLC | 942,872 | 5,929 | 0 | 0 | For |
| Invesco | 936,639 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 878,860 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 669,983 | 54 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 647,298 | 0 | 0 | 0 | For |
| Mesirow Institutional Investment Management, Inc. | 619,620 | 0 | 0 | 0 | For |
| American Century | 0 | 598,280 | 0 | 0 | Against |
| Renaissance | 525,697 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 448,025 | 21,900 | 0 | 0 | For |
| OBERWEIS ASSET MANAGEMENT INC/ | 458,400 | 0 | 0 | 0 | For |
| JPMorgan | 435,015 | 0 | 0 | 0 | For |
| Nuveen | 430,526 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 227 managers: 37,341,819 for, 6,496,052 against, 14 not voted, 413,392 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held August 22, 2023.
Combines 12 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: PROPOSAL THREE - To approve, on an advisory basis, the 2022 compensation of our named executive officers.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory basis, of 2022 compensation of our named executive officers”): 72,610,991 for, 2,909,780 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,101,996 | 0 | 0 | Against |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 356,094 | 0 | 0 | Against |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Fund voting reports, all 91 managers: 37,315,897 for, 1,465,693 against, 23,783 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 9,171,345 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,192,000 | 0 | 0 | 0 | For |
| BlackRock | 2,817,660 | 1,374 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,926,415 | 0 | 0 | 0 | For |
| Man Group plc | 1,313,460 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,150,019 | 0 | 0 | Against |
| T. Rowe Price | 1,088,082 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,016,746 | 0 | 0 | 0 | For |
| Maryland State Retirement & Pension System | 1,000,000 | 0 | 0 | 0 | For |
| Charles Schwab | 863,309 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 811,990 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Prudential/PGIM | 582,789 | 9,300 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 584,312 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 580,990 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 545,116 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 524,816 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 435,872 | 0 | 0 | 0 | For |
| Allspring | 353,410 | 0 | 0 | 0 | For |
| Voya | 298,526 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 291,401 | 5,100 | 0 | 0 | For |
| Putnam | 295,760 | 0 | 0 | 0 | For |
| AllianceBernstein | 292,660 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 281,998 | 0 | 0 | 0 | For |
Institutional-manager reports, all 201 managers: 40,579,340 for, 1,693,698 against, 563,392 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held May 21, 2024.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 99,551,894 for, 2,031,301 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,916,194 | 799 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 243,246 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 91 managers: 42,956,079 for, 799 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held August 22, 2023.
Combines 8 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: PROPOSAL FOUR - To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023”): 87,621,416 for, 277,620 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 38,783,638 for, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 118,029,526 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 10.21% |
| 2 | Vanguard | 6.51% |
| 3 | State Street | 5.01% |
| 4 | Fidelity | 2.21% |
| 5 | Dimensional | 1.96% |
| 6 | Royce | 1.24% |
| 7 | Charles Schwab | 0.86% |
| 8 | T. Rowe Price | 0.77% |
| 9 | Invesco | 0.73% |
| 10 | JANUS INVESTMENT FUND | 0.57% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 6.71% |
| 2 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.43% |
| 3 | BlackRock | 3.20% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.12% |
| 5 | Man Group plc | 2.11% |
| 6 | MARSHALL WACE, LLP | 1.23% |
| 7 | T. Rowe Price | 1.01% |
| 8 | Northern Trust | 0.97% |
| 9 | Charles Schwab | 0.91% |
| 10 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.89% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 18,216,060 | 15.43% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 8,713,520 | 7.38% | Form 13F, quarter ended March 31, 2024 |
| State Street | 8,152,902 | 6.91% | Form 13F, quarter ended March 31, 2024 |
| S | 6,229,634 | 5.28% | Schedule 13G, filed November 14, 2024 |
| Dimensional Fund Advisors | 2,737,657 | 2.32% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 2,508,152 | 2.13% | Form 13F, quarter ended March 31, 2024 |
| Renaissance Technologies | 1,888,427 | 1.60% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 1,843,624 | 1.56% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 1,429,748 | 1.21% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 1,219,418 | 1.03% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 118,029,526 shares outstanding, as reported by CATALYST PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CATALYST PHARMACEUTICALS INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held August 22, 2023 and May 21, 2024), 334 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 7,408 separate fund positions. Their filings are grouped here into 24 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held May 21, 2024 — To approve, on an advisory basis, the 2023 compensation of our named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CATALYST PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CATALYST PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CATALYST PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Proxy Votes Now, “CATALYST PHARMACEUTICALS INC. 2023-2024 Annual Meetings: Vote Results”, https://proxyvotesnow.com/company/catalyst-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.